<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>InvestorPlace &#187; Michael Murphy</title>
	<atom:link href="http://investorplace.com/author/michael-murphy/feed/" rel="self" type="application/rss+xml" />
	<link>http://investorplace.com</link>
	<description></description>
	<lastBuildDate>Sat, 25 May 2013 12:22:27 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>2 Cancer Stocks to Approach With Caution</title>
		<link>http://investorplace.com/2011/06/biotechnology-stocks-to-watch-in-war-on-cancer-dndn-miti-cldx/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=biotechnology-stocks-to-watch-in-war-on-cancer-dndn-miti-cldx</link>
		<comments>http://investorplace.com/2011/06/biotechnology-stocks-to-watch-in-war-on-cancer-dndn-miti-cldx/#comments</comments>
		<pubDate>Tue, 21 Jun 2011 16:22:22 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Stock Picks]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=46341</guid>
		<description><![CDATA[These companies are leading the pack in a new treatment for cancer, but investors should be wary.]]></description>
		<wfw:commentRss>http://investorplace.com/2011/06/biotechnology-stocks-to-watch-in-war-on-cancer-dndn-miti-cldx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:DNDN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:MITI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:CLDX</category>
		<category domain="http://rss.financialcontent.com/topic/">Stock Picks</category>
	</item>
		<item>
		<title>Biotech Stock Zalicus Soaring in 2011</title>
		<link>http://investorplace.com/2011/05/zalicus-nasdaq-zlcs-covidien-cov-exalg/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=zalicus-nasdaq-zlcs-covidien-cov-exalg</link>
		<comments>http://investorplace.com/2011/05/zalicus-nasdaq-zlcs-covidien-cov-exalg/#comments</comments>
		<pubDate>Mon, 23 May 2011 13:21:23 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Stocks to Buy]]></category>
		<category><![CDATA[Top Stocks Portfolio]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=42084</guid>
		<description><![CDATA[ZLCS stock is up over 40% in 2011 even after some profit-taking, and Michael Murphy expects the biotech to build on its run in the months ahead.]]></description>
		<wfw:commentRss>http://investorplace.com/2011/05/zalicus-nasdaq-zlcs-covidien-cov-exalg/feed/</wfw:commentRss>
		<slash:comments>9</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:ZLCS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:COV</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/"></category>
		<category domain="http://rss.financialcontent.com/topic/">Stocks to Buy</category>
		<category domain="http://rss.financialcontent.com/topic/">Top Stocks Portfolio</category>
	</item>
		<item>
		<title>Cancer Drug Should Take Dendreon to $360</title>
		<link>http://investorplace.com/2011/05/biotech-stock-to-buy-dendreon-corp-nasdaq-dndn/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=biotech-stock-to-buy-dendreon-corp-nasdaq-dndn</link>
		<comments>http://investorplace.com/2011/05/biotech-stock-to-buy-dendreon-corp-nasdaq-dndn/#comments</comments>
		<pubDate>Tue, 03 May 2011 08:00:06 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Stocks to Buy]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=39399</guid>
		<description><![CDATA[Dendreon Corp. (NASDAQ: DNDN) revolutionary cancer vaccine Provenge should make this biotech stock a huge winner.]]></description>
		<wfw:commentRss>http://investorplace.com/2011/05/biotech-stock-to-buy-dendreon-corp-nasdaq-dndn/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:DNDN</category>
		<category domain="http://rss.financialcontent.com/topic/">Stocks to Buy</category>
	</item>
		<item>
		<title>Zalicus Proves It&#8217;s the Best &#8217;11 Stock</title>
		<link>http://investorplace.com/2011/03/zalicus-zlcs-biotech-stock-biotechnology-investmen/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=zalicus-zlcs-biotech-stock-biotechnology-investmen</link>
		<comments>http://investorplace.com/2011/03/zalicus-zlcs-biotech-stock-biotechnology-investmen/#comments</comments>
		<pubDate>Thu, 10 Mar 2011 13:06:19 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Stock Picks]]></category>
		<category><![CDATA[Top Stocks Portfolio]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=33295</guid>
		<description><![CDATA[Michael Murphy picked leading biotech stock Zalicus as his single best stock to buy in 2011. With +36% gains since Jan. 1, he was right.]]></description>
		<wfw:commentRss>http://investorplace.com/2011/03/zalicus-zlcs-biotech-stock-biotechnology-investmen/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:ZLCS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:COV</category>
		<category domain="http://rss.financialcontent.com/topic/">Stock Picks</category>
		<category domain="http://rss.financialcontent.com/topic/">Top Stocks Portfolio</category>
	</item>
		<item>
		<title>Best Biotech Stock for 2011 &#8211; Zalicus (ZLCS)</title>
		<link>http://investorplace.com/2010/12/zalicus-zlcs-best-biotech-stock-pick-2011/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=zalicus-zlcs-best-biotech-stock-pick-2011</link>
		<comments>http://investorplace.com/2010/12/zalicus-zlcs-best-biotech-stock-pick-2011/#comments</comments>
		<pubDate>Mon, 27 Dec 2010 19:45:57 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Hot Stocks]]></category>
		<category><![CDATA[Top Stocks Portfolio]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=25996</guid>
		<description><![CDATA[Zalicus (NASDAQ:ZLCS) is Michael Murphy's favorite biotech stock picks for 2011.]]></description>
		<wfw:commentRss>http://investorplace.com/2010/12/zalicus-zlcs-best-biotech-stock-pick-2011/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:ZLCS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">AMEX:AIS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:SNY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:NOV</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:COV</category>
		<category domain="http://rss.financialcontent.com/topic/">Hot Stocks</category>
		<category domain="http://rss.financialcontent.com/topic/">Top Stocks Portfolio</category>
	</item>
		<item>
		<title>Oracle’s REAL Buyout Targets</title>
		<link>http://investorplace.com/2010/09/oracles-real-buyout-targets/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=oracles-real-buyout-targets</link>
		<comments>http://investorplace.com/2010/09/oracles-real-buyout-targets/#comments</comments>
		<pubDate>Fri, 24 Sep 2010 20:36:19 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Market Insight: Financial Articles]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=18596</guid>
		<description><![CDATA[As Oracle (NASDAQ: ORCL) held its annual meeting this week, CEO Larry Ellison said: “You’re going to see us buying chip companies.”  He added that now that Oracle is in the hardware business through its acquisition of Sun Microsystems, he wants to follow the model of his friend and Apple CEO Steve Jobs to own more of the intellectual property in the computer chips Oracle will be using.]]></description>
		<wfw:commentRss>http://investorplace.com/2010/09/oracles-real-buyout-targets/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:ORCL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:ARMH</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:AMD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:NVDA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:IBM</category>
		<category domain="http://rss.financialcontent.com/topic/">Market Insight: Financial Articles</category>
	</item>
		<item>
		<title>Housing Market Short Sales Are Your Best Investment Option Now</title>
		<link>http://investorplace.com/2010/08/housing-market-short-sales-are-your-best-investment-option-now/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=housing-market-short-sales-are-your-best-investment-option-now</link>
		<comments>http://investorplace.com/2010/08/housing-market-short-sales-are-your-best-investment-option-now/#comments</comments>
		<pubDate>Tue, 17 Aug 2010 13:35:51 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Market Insight: Financial Articles]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=14953</guid>
		<description><![CDATA[The recession is “officially” over according to GDP figures. Stocks are up +50% from the March 2009 bottom. Gold and silver are up dramatically, too. So what’s the only remaining asset class that’s still cheap? ]]></description>
		<wfw:commentRss>http://investorplace.com/2010/08/housing-market-short-sales-are-your-best-investment-option-now/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:BAC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:JPM</category>
		<category domain="http://rss.financialcontent.com/topic/">Market Insight: Financial Articles</category>
	</item>
		<item>
		<title>Business Development Companies Offer Big Dividend Opportunities</title>
		<link>http://investorplace.com/2010/08/business-development-companies-offer-big-dividend-opportunities/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=business-development-companies-offer-big-dividend-opportunities</link>
		<comments>http://investorplace.com/2010/08/business-development-companies-offer-big-dividend-opportunities/#comments</comments>
		<pubDate>Mon, 16 Aug 2010 18:24:26 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Dividend Stocks]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=14882</guid>
		<description><![CDATA[Business development companies or BDC are registered under the Investment Company Act of 1940, like mutual funds. But instead of investing in public securities, they generally invest in private companies. ]]></description>
		<wfw:commentRss>http://investorplace.com/2010/08/business-development-companies-offer-big-dividend-opportunities/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:BKCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:AINV</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:ARCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:FSC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:KCAP</category>
		<category domain="http://rss.financialcontent.com/topic/">Dividend Stocks</category>
	</item>
		<item>
		<title>Apple Supplier Skyworks a Great Buy</title>
		<link>http://investorplace.com/2010/08/apple-supplier-skyworks-a-great-buy/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=apple-supplier-skyworks-a-great-buy</link>
		<comments>http://investorplace.com/2010/08/apple-supplier-skyworks-a-great-buy/#comments</comments>
		<pubDate>Fri, 06 Aug 2010 12:20:32 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Gadgets, Smartphones & Tech]]></category>
		<category><![CDATA[Hot Stocks]]></category>
		<category><![CDATA[Stock Picks]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=13723</guid>
		<description><![CDATA[Sales to Apple were a big driver of the excellent quarterly results [Skyworks reported last month], and will continue to create strong revenue growth this year. Apple obviously is very happy with SWKS as a supplier, and Skyworks also supplies all the leading smart phone manufacturers.]]></description>
		<wfw:commentRss>http://investorplace.com/2010/08/apple-supplier-skyworks-a-great-buy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:SWKS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:AAPL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:MOT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:VZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:NOK</category>
		<category domain="http://rss.financialcontent.com/topic/">Gadgets, Smartphones &amp; Tech</category>
		<category domain="http://rss.financialcontent.com/topic/">Hot Stocks</category>
		<category domain="http://rss.financialcontent.com/topic/">Stock Picks</category>
	</item>
		<item>
		<title>Trading Strategies &#8211; Why Barbell Investing is the New Normal</title>
		<link>http://investorplace.com/2010/07/trading-strategies-why-barbell-investing-is-the-new-normal/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=trading-strategies-why-barbell-investing-is-the-new-normal</link>
		<comments>http://investorplace.com/2010/07/trading-strategies-why-barbell-investing-is-the-new-normal/#comments</comments>
		<pubDate>Mon, 26 Jul 2010 18:12:54 +0000</pubDate>
		<dc:creator>Michael Murphy</dc:creator>
				<category><![CDATA[Market Insight: Financial Articles]]></category>

		<guid isPermaLink="false">http://investorplace.com/?p=12752</guid>
		<description><![CDATA[If using pyramid advice to manage your portfolio going forward can’t get you to where you want to be, why do it? ]]></description>
		<wfw:commentRss>http://investorplace.com/2010/07/trading-strategies-why-barbell-investing-is-the-new-normal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
			<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:C</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:NLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">AMEX:WAC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NYSE:TNK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol/">NASDAQ:BKCC</category>
		<category domain="http://rss.financialcontent.com/topic/">Market Insight: Financial Articles</category>
	</item>
	</channel>
</rss>